| EBR Systems Inc (EBR) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Health Care |
$412 |
Application for quotation of securities - EBR
|
10 Dec 2025 11:15AM |
$0.940 |
$0.915 |
fallen by
2.66%
|
|
| Green360 Technologies Limited (GT3) ORDINARY FULLY PAID |
Materials |
$45 |
Notification of cessation of securities - GT3
|
10 Dec 2025 11:14AM |
$0.036 |
$0.037 |
risen by
2.78%
|
|
| Emu NL (EMU) ORDINARY FULLY PAID |
Materials |
$11 |
Change in substantial holding
|
10 Dec 2025 10:51AM |
$0.048 |
$0.045 |
fallen by
6.25%
|
|
| IPH Limited (IPH) ORDINARY FULLY PAID |
Industrials |
$939 |
Change of Director's Interest Notice
|
10 Dec 2025 10:49AM |
$3.445 |
$3.590 |
risen by
4.21%
|
|
| Vita Life Sciences Limited (VLS) ORDINARY FULLY PAID |
Health Care |
$141 |
Notification of cessation of securities - VLS
|
10 Dec 2025 10:48AM |
$2.430 |
$2.580 |
risen by
6.17%
|
|
| WAM Strategic Value Limited (WAR) ORDINARY FULLY PAID |
Financials |
$205 |
November 2025 Investment Update
|
10 Dec 2025 10:44AM |
$1.125 |
$1.140 |
risen by
1.33%
|
|
| Finder Energy Holdings Limited (FDR) ORDINARY FULLY PAID |
Energy |
$170 |
Petrojarl I Webinar Presentation
|
10 Dec 2025 10:36AM |
$0.380 |
$0.385 |
risen by
1.32%
|
|
FDR - Price-sensitive ASX Announcement
Full Release
Key Points
- US$9.0m in FDR shares issued to Amplus, subject to shareholder approval.
- Additional US$6m cash payment in stages, linked to FID and project milestones.
- Completion of PJI acquisition expected in December 2025.
- Strategic alliance with SLB to accelerate project delivery and first oil.
- Petrojarl I acquisition seen as a fast and cost-effective redeployment solution.
- Significant economic benefits expected from reduced operating expenses.
- Amplus to receive contracts for FPSO FEED, modifications, and management.
- Aim to achieve FID by mid-2026 and first oil by year-end 2027.
- Major shareholder committed to supporting resolutions at the EGM.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| National Storage REIT (NSR) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$3,847 |
Disclosure under Takeovers Panel GN 20 - Equity Derivatives
|
10 Dec 2025 10:34AM |
$2.790 |
$2.740 |
fallen by
1.79%
|
|
| Toubani Resources Inc (TRE) ORDINARY FULLY PAID |
Materials |
$254 |
Application for quotation of securities - TRE
|
10 Dec 2025 10:33AM |
$0.355 |
$0.400 |
risen by
12.68%
|
|
| hipages Group Holdings Limited (HPG) ORDINARY FULLY PAID |
Communication Services |
$170 |
Change of Director's Interest Notice - KM
|
10 Dec 2025 10:30AM |
$1.285 |
$1.240 |
fallen by
3.50%
|
|
| Pengana Private Equity Trust (PE1) ORDINARY UNITS FULLY PAID |
Financials |
$366 |
Monthly Performance Report - November 2025
|
10 Dec 2025 10:29AM |
$1.320 |
$1.370 |
risen by
3.79%
|
|
| Pengana Global Private Credit Trust (PCX) ORDINARY UNITS FULLY PAID |
Financials |
$234 |
PCX Monthly Newsletter - November 2025
|
10 Dec 2025 10:28AM |
$1.990 |
$2.020 |
risen by
1.51%
|
|
| Radiopharm Theranostics Limited (RAD) ORDINARY FULLY PAID |
Health Care |
$89 |
Ceasing to be a substantial holder PH
|
10 Dec 2025 10:26AM |
$0.019 |
$0.025 |
risen by
31.58%
|
|
| hipages Group Holdings Limited (HPG) ORDINARY FULLY PAID |
Communication Services |
$170 |
Notification regarding unquoted securities - HPG
|
10 Dec 2025 10:25AM |
$1.285 |
$1.240 |
fallen by
3.50%
|
|
| InhaleRx Limited (IRX) ORDINARY FULLY PAID |
Health Care |
$6 |
IRX Overview Presentation - SRX-25 and Nexalis
|
10 Dec 2025 10:24AM |
$0.025 |
$0.024 |
fallen by
4%
|
|
IRX - Price-sensitive ASX Announcement
Full Release
Key Points
- InhaleRx Limited is developing three drug candidates for unmet needs in pain management and mental health.
- SRX-25 is an oral esketamine and CYP-450 inhibitor for treatment-resistant depression.
- IRX-211 targets breakthrough cancer pain and is in Phase 2 trials with FDA approval pathways defined.
- IRX-616a is an inhaled therapy for panic disorder with an opportunity due to lack of FDA-approved inhaled treatments.
- All programs are fully funded through the Linlithgow Family Office agreement.
- The company is rebranding to Nexalis Therapeutics to reflect its expanded drug portfolio.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Charger Metals NL (CHR) ORDINARY FULLY PAID |
Materials |
$10 |
Appendix 3A.6 Notification of Call
|
10 Dec 2025 10:24AM |
$0.084 |
$0.130 |
risen by
54.76%
|
|
| BTC Health Ltd (BTC) ORDINARY FULLY PAID |
Financials |
$22 |
Net Tangible Asset Backing - 30 November 2025
|
10 Dec 2025 10:21AM |
$0.060 |
$0.062 |
risen by
3.33%
|
|
| Anagenics Limited (AN1) ORDINARY FULLY PAID |
Consumer Staple |
$3 |
Proposed issue of securities - AN1
|
10 Dec 2025 10:20AM |
$0.005 |
$0.005 |
fallen by
0%
|
|
| Anagenics Limited (AN1) ORDINARY FULLY PAID |
Consumer Staple |
$3 |
Proposed issue of securities - AN1
|
10 Dec 2025 10:20AM |
$0.005 |
$0.005 |
fallen by
0%
|
|
| Anagenics Limited (AN1) ORDINARY FULLY PAID |
Consumer Staple |
$3 |
Proposed issue of securities - AN1
|
10 Dec 2025 10:20AM |
$0.005 |
$0.005 |
fallen by
0%
|
|
| Anagenics Limited (AN1) ORDINARY FULLY PAID |
Consumer Staple |
$3 |
Placement of Shares
|
10 Dec 2025 10:20AM |
$0.005 |
$0.005 |
fallen by
0%
|
|
AN1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Two-tranche placement to raise A$2.25 million.
- First tranche to raise $342,461 through 74,448,054 shares.
- Second tranche to raise $1,907,539 through 414,682,381 shares, subject to approval.
- Funds used for brand expansion, business opportunities, debt retirement, and costs.
- Shares priced at $0.0046, 8% discount to recent VWAP.
- Participants receive a 6% selling fee plus GST and unlisted alignment options.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Anax Metals Limited (ANX) ORDINARY FULLY PAID |
Materials |
$21 |
Strategic Placement Completed and Cleansing Notice
|
10 Dec 2025 10:19AM |
$0.010 |
$0.019 |
risen by
90%
|
|
| Charger Metals NL (CHR) ORDINARY FULLY PAID |
Materials |
$10 |
Charger Metals NL Partly Paid Shares Call
|
10 Dec 2025 10:19AM |
$0.084 |
$0.130 |
risen by
54.76%
|
|
CHR - Price-sensitive ASX Announcement
Full Release
Key Points
- Charger Metals NL announced a call of $0.02 per share on its CHR Partly Paid Shares to raise up to $854,175.
- Payment for the call is due by 24 December 2025, after which shares may be forfeited if the call is not paid.
- The funds will support drilling and exploration at the Medcalf Resource, Medcalf West Target, and general working capital.
- Directors intend to pay the call on part of their holdings, totaling $79,938.
- Charger Metals holds significant lithium exploration projects, including the Medcalf Lithium Deposit with an estimated resource of 8.2Mt @ 1.0% Li2O.
- The Bynoe Lithium Project is another key asset, adjacent to Core Lithium's Finniss Project.
- Shareholders are encouraged to receive communications electronically to reduce costs and environmental impact.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Charger Metals NL (CHR) ORDINARY FULLY PAID |
Materials |
$10 |
Charger Retains 100% of Lake Johnston Lithium & Gold Project
|
10 Dec 2025 10:18AM |
$0.084 |
$0.130 |
risen by
54.76%
|
|
CHR - Price-sensitive ASX Announcement
Full Release
Key Points
- Charger retains 100% of Lake Johnston Lithium and Gold Project.
- Rio Tinto Exploration withdraws from the project agreement.
- RTX funded $4.2 million in exploration and subscribed $1.2 million in equity.
- Medcalf Maiden Inferred Resource stands at 8.2Mt @ 1.0% Li2O.
- Future exploration includes drilling at Medcalf and Medcalf West.
- Assays pending for 3,012m from recent drill program.
- Next drilling campaign planned for January 2026.
- Whitten prospect showed significant lithium mineralisation in one drill hole.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Anax Metals Limited (ANX) ORDINARY FULLY PAID |
Materials |
$21 |
Application for quotation of securities - ANX
|
10 Dec 2025 10:15AM |
$0.010 |
$0.019 |
risen by
90%
|
|